10 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
> Low dose ICS/LABA ... nonpharmacologic management ... Stepwise #Therapy #Management ... #Pharmacology # ... Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... Treatment #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
Amiodarone Toxicity and Monitoring

Tremor Ataxia 
Ocular neuritis 
Corneal Microdeposits 
Bradycardia 
Pulmonary fibrosis 
Hepatotoxicity 
Blue-gray skin
Amiodarone Toxicity ... Bradycardia Pulmonary ... #Amiodarone #Toxicity ... Adverse #Diagnosis #Management ... #Pharmacology
Salicylate Toxicity - Diagnosis and Management

Consider if:
1) Patient is hot and altered
2) You see tachypnea with
Salicylate Toxicity ... respiratory cause 3) Labs ... , Diaphoresis, Pulmonary ... edema, Shock Labs ... Salicylate #Aspirin #Toxicity
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
solitary and multiple pulmonary ... pneumonia - Pulmonary ... Labs: • Nonspecific ... #Pulmonary #diagnosis ... #management #Toxicology
Salicylate Poisoning - Toxicology

Acute toxicity = vomiting, tachypnea, tinnitus, diaphoresis, and lethargy. This may progress to
hyperthermia, coma, and pulmonary ... Chronic toxicity ... Cerebral and pulmonary ... #Toxicology #Pharmacology ... #Diagnosis #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... differential #algorithm #management ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Infection (Diffuse Pulmonary ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology